References
Bell WR, Tomasulo PA, Alving BM, Duffy TP. Thrombocytopenia occurring during the administration of heparin: a prospective study in 52 patients. Ann Intern Med 1976;85:155–160.
Nelson JC, Lerner RG, Goldstein R, Cagin NA. Heparin-induced thrombocytopenia. Arch Intern Med 1978;138:548–552.
Warkentin TE, Levin MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330–1335.
Schmitt PB, Adelman B. Heparin-associated thrombocytopenia: a critical review and a pooled analysis. Am J Med Sci 1993;305:208–215.
Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996;101:502–507.
Arnout J. The Pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb & Haemost 1996;75:536–541.
Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994;83:1535–1541.
Warkentin TE, Hayward CPM, Boshkov LK, et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994;84:3691–3699.
Cines DB, Tomaski A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 1987;316:581–589.
Hach-Wunderle V, Kainer K, Krug B, Müller-Berghaus G, Pötzsch B. Heparin-associated thrombosis despite normal platelet counts (letter). Lancet 1994;344:469–470.
Warkentin TE. Heparin-induced skin lesions. Br J Haematol 1996;92:494–497.
Towne JB, Bernhard VM, Hussey C, et al. White clot syndrome. Peripheral vascular complications of heparin therapy. Arch Surg 1979;114:372–377.
Benhamou AC, Gruel Y, Barsotti J, et al. The white clot syndrome or heparin associated thrombocytopenia and thrombosis (WCS or HATT): (26 cases). Int Angiol 1985;4:303–310.
Chang JC. White clot syndrome associated with heparin-induced thrombocytopenia: a review of 23 cases. Heart Lung 1987;16:403–407.
Boshkov LK, Warkentin TE, Hayward CPM, Andrew M, Kelton JG. Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Haematol 1993;84:322–328.
Kyntsis AP, Williams EL, Schutta HS. Cerebral venous thrombosis due to heparin-induced thrombocytopenia. Stroke 1990;21:1503–1505.
Arthur CK, Grant SJB, Murray WK, Isbister JP, Stiel JN, Lauer CS. Heparin-associated acute adrenal insufficiency (letter). Aust NZ J Med 1985;15:454–455.
Ernest D, Fisher MM. Heparin-induced thrombocytopenia complicated by bilateral adrenal haemorrhage. Intens Care Med 1991;17:238–240.
Warkentin TE, Elavathil LJ, Hayward CPM, Johnston MA, Russet JI, Kelton JG. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Int Med 1997;127:805–812.
Hartman AR, Hood RM, Anagnostopoulos CE. Phenomenon of heparin-induced thrombocytopenia associated with skin necrosis. J Vasc Surg 1988;7: 781–782.
Warkentin TE. Heparin-induced skin lesions. Br J Haematol 1996;92:494–497.
Warkentin TE, Soutar RL, Panju A, Ginsberg JS. Acute systemic reactions to intravenous bolus heparin therapy: characterization and relationship to heparin-induced thrombocytopenia. Immunohematology 1997;160a.
Warkentin TE, Hirte HW, Anderson DR, et al. Transient global amnesia associated with acute heparin-induced thrombocytopenia. Am J Med 1994;97:489–491.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spencer, F.A. Heparin-Induced Thrombocytopenia: Patient Profiles and Clinical Manifestations. J Thromb Thrombolysis 10 (Suppl 1), 21–25 (2000). https://doi.org/10.1023/A:1027325002276
Issue Date:
DOI: https://doi.org/10.1023/A:1027325002276